DISCOVERY OF A NOVEL AND POTENT CHOLESTEROL ABSORPTION INHIBITOR AS PROMISING ORALLY ACTIVE LIPID LOWERING DRUG

被引：0
|
作者：
Kanou, M. [1 ]
Nishiwaki, Y. [2 ]
Nakano, A. [2 ]
Yamanaka, Y. [2 ]
机构：
[1] Teijin Pharma Ltd, Pharmaceut Dev Res Labs, Tokyo, Japan
[2] Teijin Pharma Ltd, Pharmaceut Discovery Res Labs, Tokyo, Japan
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2010年 / 11卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(10)70360-3
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P293
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [31] Discovery of DS42450411 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4-aminopyrimidine derivatives
    Fukuda, Takeshi
    Ishiyama, Takashi
    Katagiri, Takahiro
    Ueda, Kenjiro
    Muramatsu, Sumie
    Hashimoto, Masami
    Aki, Anri
    Baba, Daichi
    Watanabe, Kengo
    Tanaka, Naoki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (20) : 3333 - 3337
  • [32] Discovery of potent, orally active benzimidazole glucagon receptor antagonists
    Kim, Ronald M.
    Chang, Jiang
    Lins, Ashley R.
    Brady, Ed
    Candelore, Mari R.
    Dallas-Yang, Qing
    Ding, Victor
    Dragovic, Jasminka
    Iliff, Susan
    Jiang, Guoqiang
    Mock, Steven
    Qureshi, Sajjad
    Saperstein, Richard
    Szalkowski, Deborah
    Tamvakopoulos, Constantin
    Tota, Laurie
    Wright, Michael
    Yang, Xiaodong
    Tata, James R.
    Chapman, Kevin
    Zhang, Bei B.
    Parmee, Emma R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (13) : 3701 - 3705
  • [33] Discovery of potent and orally active farnesyltransferase (FT) inhibitors.
    Tong, YS
    Wang, L
    Hasvold, L
    Leonard, N
    Li, TM
    Li, Q
    Wang, WB
    Cohen, J
    Gu, WZ
    Zhang, HY
    Bauch, J
    Marsh, K
    Rosenberg, SH
    Lin, NH
    Sham, HL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U29 - U29
  • [34] Discovery of novel tetracyclic tetrahydrofuran derivatives as potent, orally active, broad spectrum psychotropic agents
    Alonso, JM
    Andrés, JI
    Cid, JM
    Díaz, A
    Fernández, J
    Iturrino, L
    Gil, P
    Megens, A
    Sipido, VK
    Trabanco, AA
    Proceedings of the Joint Meeting on Medicinal Chemistry, 2005, : 63 - 66
  • [35] Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists
    Amaudrut, Jerome
    Argiriadi, Maria A.
    Barth, Martine
    Breinlinger, Eric C.
    Bressac, Didier
    Broqua, Pierre
    Calderwood, David J.
    Chatar, Mohamed
    Cusack, Kevin P.
    Gauld, Stephen B.
    Jacquet, Sebastien
    Kamath, Rajesh, V
    Kort, Michael E.
    Lepais, Valerie
    Luccarini, Jean-Michel
    Masson, Philippe
    Montalbetti, Christian
    Mounier, Laurent
    Potin, Dominique
    Poupardin, Olivia
    Rouaud, Sylvie
    Spitzer, Luc
    Wallace, Craig D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (14) : 1799 - 1806
  • [36] Discovery of a novel, potent and orally active series of γ-lactams as selective NK1 antagonists
    Paliwal, Sunil
    Reichard, Gregory A.
    Shah, Sapna
    Wrobleski, Michelle Laci
    Wang, Cheng
    Stengone, Carmine
    Tsui, Hon-Chung
    Xiao, Dong
    Duffy, Ruth A.
    Lachowicz, Jean E.
    Nomeir, Amin A.
    Varty, Geoffrey B.
    Shih, Neng-Yang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 4168 - 4171
  • [37] Discovery of a novel and orally active dual inhibitor of NEP and ACE: Synthesis and pharmacology.
    Kotake, M
    Suda, S
    Oinuma, H
    Yoneda, N
    Matsushima, T
    Mori, N
    Daiku, Y
    Saito, M
    Matsuoka, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U37 - U37
  • [38] Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitors
    Pinard, Emmanuel
    Alberati, Daniela
    Bender, Markus
    Borroni, Edilio
    Brom, Virginie
    Burner, Serge
    Fischer, Holger
    Hainzl, Dominik
    Halm, Remy
    Hauser, Nicole
    Jolidon, Synese
    Lengyel, Judith
    Marty, Hans-Peter
    Meyer, Thierry
    Moreau, Jean-Luc
    Mory, Roland
    Narquizian, Robert
    Norcross, Roger D.
    Schmid, Philipp
    Wermuth, Roger
    Zimmerli, Daniel
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 6960 - 6965
  • [39] Discovery of novel, potent, and orally active spiro-urea human glucagon receptor antagonists
    Shen, DM
    Zhang, FQ
    Brady, EJ
    Candelore, MR
    Dallas-Yang, Q
    Ding, VDH
    Dragovic, J
    Feeney, WP
    Jiang, GQ
    McCann, PE
    Mock, S
    Qureshi, SA
    Saperstein, R
    Shen, XL
    Tamvakopoulos, C
    Tong, X
    Tota, LM
    Wright, MJ
    Yang, XD
    Zheng, S
    Chapman, KT
    Zhang, BB
    Tata, JR
    Parmee, ER
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (20) : 4564 - 4569
  • [40] Discovery of novel lipid lowering agents.
    Biller, SA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U204 - U205
12345